Profile
Adam Friedman is the founder of Zylö Therapeutic, Inc. which was founded in 2017.
He is currently working as a Professor & Chair-Dermatology at George Washington University since 2018.
Adam Friedman active positions
Companies | Position | Start |
---|---|---|
George Washington University | Corporate Officer/Principal | 2018-05-31 |
Zylö Therapeutic, Inc.
Zylö Therapeutic, Inc. BiotechnologyHealth Technology Zylö Therapeutic, Inc. develops a drug-delivery system designed to deliver notoriously hard-to-deliver therapeutic agents. The frim offers patented platform technology that leverages hydrogel-derived nanoparticles to deliver in a sustained and controlled manner therapeutic agents through topical administration, enabling the healthcare industry to harness the therapeutic potential across a variety of applications. The company was founded by Scott R. Pancoast, Joel M. Friedman, Adam Friedman, Lance M. White and Gary J. G. Atkinsonin November 2017 in and is headquartered in Greenville, SC. | Founder | 2017-10-31 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 1 |
---|---|
Zylö Therapeutic, Inc.
Zylö Therapeutic, Inc. BiotechnologyHealth Technology Zylö Therapeutic, Inc. develops a drug-delivery system designed to deliver notoriously hard-to-deliver therapeutic agents. The frim offers patented platform technology that leverages hydrogel-derived nanoparticles to deliver in a sustained and controlled manner therapeutic agents through topical administration, enabling the healthcare industry to harness the therapeutic potential across a variety of applications. The company was founded by Scott R. Pancoast, Joel M. Friedman, Adam Friedman, Lance M. White and Gary J. G. Atkinsonin November 2017 in and is headquartered in Greenville, SC. | Health Technology |
- Stock Market
- Insiders
- Adam Friedman